Merck KGaA (XSWX:MER)
CHF 223 0 (0%) Market Cap: 77.56 Bil Enterprise Value: 86.30 Bil PE Ratio: 24.98 PB Ratio: 2.30 GF Score: 90/100

Half Year 2021 Merck KGaA Earnings Call Transcript

Aug 05, 2021 / 12:00PM GMT
Release Date Price: CHF130
Operator

Dear, ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on Second Quarter for 2021. (Operator Instructions) May I now hand you over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest
MERCK Kommanditgesellschaft auf Aktien - Head of IR

Yes, ladies and gentlemen, a very, very warm welcome from my side. My name is Constantin Fest. I'm Head of Investor Relations, and a warm welcome to this Q2 2021 Earnings Release Call. For the presentation as well as for the Q&A part of this call. We have here today with us, Belen Garijo, CEO of the group; as well as Marcus Kuhnert, CFO of the group.

For the Q&A part, we also have with us here today Peter Guenter, CEO of Healthcare; as well as Matthias Heinzel, CEO of Life Science; and Kai Beckmann, CEO of Electronics.

One housekeeping item for the Q&A, if I may. Please be aware that we have room for 2 questions and also kindly refrain from multipart questions. This helps maximizing the amount

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot